Innate lymphoid cells activated by the cytokine TL1A link colitis to emergency granulopoiesis and the recruitment of tumor-promoting neutrophils.

Publication Type Academic Article
Authors Pires S, Yang W, Frigerio S, Louis C, Scott C, Zhou Y, Cardakli E, Tran N, Hassan-Zahraee M, Ye Z, Hyde C, Hung K, Chen A, Ng C, Grier A, Lukin D, Scherl E, Targan S, Diehl G, Grootjans J, Putoczki T, Wicks I, Longman R
Journal Immunity
Volume 59
Issue 2
Pagination 372-387.e7
Date Published 01/22/2026
ISSN 1097-4180
Keywords Tumor Necrosis Factor Ligand Superfamily Member 15, Neutrophils, Colitis, Lymphocytes, Granulocytes, Colorectal Neoplasms
Abstract Inflammatory bowel disease (IBD) increases the risk of colorectal cancer (CRC). Genetic variants in TNFSF15, encoding tumor necrosis factor (TNF)-like cytokine 1A (TL1A), associate with severe IBD and advanced CRC. Here, we investigated how TL1A signaling promotes colitis-associated tumorigenesis. Deletion of the TL1A receptor in tissue-resident type 3 innate lymphoid cells (ILC3s) reduced colitis-associated tumorigenesis. TL1A signaling promoted neutrophil recruitment to the colon, which was required for tumor development. TL1A-stimulated ILC3s activated neutrophils, inducing a tumor-associated neutrophil (TAN)-like gene signature, and transfer of these neutrophils was sufficient to promote tumor growth. A similar TAN-like gene signature was enriched in human colitis-associated dysplasia but reduced following TL1A blockade in ulcerative colitis patients. Mechanistically, TL1A and colitis triggered emergency granulopoiesis, expanding granulocyte-monocyte progenitors and neutrophils in a manner dependent on ILC3-derived granulocyte-macrophage colony-stimulating factor (GM-CSF). Thus, a TL1A-ILC3-GM-CSF axis links colitis with emergency granulopoiesis and may serve as a therapeutic target to reduce colitis-associated CRC.
DOI 10.1016/j.immuni.2025.12.008
PubMed ID 41576959
PubMed Central ID PMC12981380
Back to Top